Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
18
2015
Growing Issues In A Miniature World: Nanomaterial Registers In The EU Squire Patton Boggs (US) LLP
Feb
16
2015
Revised Seed Law Expected to Come into Effect Soon in China Michael Best & Friedrich LLP
Feb
13
2015
DEA Rules On Disposal of Controlled Substances - What's Up? Poyner Spruill LLP
Feb
12
2015
Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
Feb
12
2015
Interface without Regulation – FDA Deregulates MDDS and Related Technologies Sheppard, Mullin, Richter & Hampton LLP
Feb
12
2015
Medicare Fraud Plea in Detroit Pill Mill Case Mahany Law
Feb
12
2015
Filthy Pharma Chronicles – GVK Bio Fake Drug Trials Mahany Law
Feb
12
2015
Pharmaceutical Manufacturer Agrees to Pay U.S. Government $7.9 Million for Alleged Kickback Scheme Tycko & Zavareei LLP
Feb
11
2015
FDA Will Not Enforce Regulatory Controls for Medical Device Data Systems and Two Other Health IT Devices McDermott Will & Emery
Feb
11
2015
European Study Finds Moderate Caffeine Use Safe Morgan, Lewis & Bockius LLP
Feb
11
2015
Biosimilars Update re: Biologics Price Competition and Innovation Act Proskauer Rose LLP
Feb
11
2015
House To Consider Keystone, Tax Extenders; Senate To Vote On Director Of National Drug Control Policy
Feb
11
2015
Senate Takes Shot At Vaccine-Preventable Diseases; Health Cybersecurity Examined; GAO Reports On ICD-10 Squire Patton Boggs (US) LLP
Feb
11
2015
FTC Tastes “Sweet” Victory: The Implications of POM Wonderful for Government Practice Mintz
Feb
10
2015
Clinical Trial Data: Shared Resource or Private Property? Faegre Drinker
Feb
10
2015
Important Developments in FDA Regulation of Software, Including Mobile Apps Covington & Burling LLP
Feb
10
2015
Exploring Indian Country Marijuana Godfrey & Kahn S.C.
Feb
10
2015
Seventh Circuit Says Assignment Law Not a Basis for FCA Suit (False Claims Act Suit) McDermott Will & Emery
Feb
10
2015
China Struggles With Food Safety Covington & Burling LLP
Feb
9
2015
Out-of-Market Divestiture Required to Resolve Competitive Concerns McDermott Will & Emery
Feb
9
2015
FDA Issues Draft Guidance on Combination Product Manufacturing Covington & Burling LLP
Feb
9
2015
Alcohol & Tobacco Tax & Trade Bureau (TTB) Publishes Semi-Annual Regulatory Agenda with Plans and Goals for the Coming Year McDermott Will & Emery
Feb
7
2015
21st Century Cures Discussion Draft Act Proposes Changes to Medical Device Regulation Covington & Burling LLP
Feb
6
2015
Testosterone Replacement Clinic Agrees to Pay the Government $1.6 Million for Alleged Medicaid Fraud Tycko & Zavareei LLP
Feb
6
2015
FDA Issues Draft Guidances Aimed at Reducing Oversight of Low Risk General Wellness Products and Medical Device Accessories Greenberg Traurig, LLP
Feb
6
2015
Nice Insight on Trends and Expectations for Outsourcing in the Biopharmaceutical Industry Morgan, Lewis & Bockius LLP
Feb
6
2015
Mixing Things Up: Let’s Talk Recipes, Part One of a Four-Part Series on Copyright Lewis Roca Rothgerber LLP
Feb
6
2015
Is Compulsory Licensing of Generic Medicines Coming to the Russian Federation? Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins